Exploring the mechanism of action of bei shashen-maidong in the treatment of non-small cell lung cancer based on network pharmacology and experimental validation

Beishashen(BSS)and Maidong(MD)are commonly used Medicine right for the treatment of non-small cell lung cancer(NSCLC),but their specific mechanism of action is not clear.In this study,network pharmacology and molecular docking techniques were used to investigate the molecular mechanisms of the therapeutic effects of BSS-MD on NSCLC and to experimentally validate some of the targets.The network pharmacology approach,including active ingredient and target screening,drug-compound-target network construction,protein-protein interaction(PPI)network,enrichment analysis,and molecular docking,was used to investigate the mechanism of action of Beisashen and Maitong on NSCLC.First,the active components of BSS-MD and their targets were predicted,of which 423 targets interacted with NSCLC targets.Then,network pharmacology showed that Stigmasterol,Quercetin,Alloisoimperatorin,Isoimperatorin,Beta-sitosterol were the core components of BSS-MD,and PLK1,HSP90AB1,and CDK1 were the key therapeutic targets.KEGG enrichment analysis indicated that the mechanism of action of BSS-MD in NSCLC treatment was related to the cell cycle.Then we further performed experimental validation.CCK-8 assay showed that BSS-MD inhibited LEWIS cell viability and promoted apoptosis in a dose-dependent manner.qPCR assay,immunofluorescence,and protein blotting experiments demonstrated that compared with the control group and the control group,the expression of PLK1,HSP90AB1,and CDK1 mRNAs and proteins were reduced in the treatment group(P<0.01).Therefore,we conclude that BSS-MD can block cell cycle progression by inhibiting the expression of PLK1,CDK1,and HSP90AB1 mRNAs and proteins to inhibit lung cancer cell growth and promote apoptosis,and emphasize that BSS-MD are promising adjuvants for NSCLC treatment.

Quality of life and psychological outcome of donors after living donor liver transplantation

AIM: To investigate the health related quality of life (HRQoL) and psychological outcome of donors after living donor liver transplantation. METHODS: Participants were 92 consecutive liver transplant donors who underwent hepatectomy with- out middle hepatic vein at West China Hospital of Sichuan University between January 2007 and Sep- tember 2010. HRQoL was measured using the Chinese version of the Medical Outcomes Study Short Form-36 (SF-36), and psychological symptoms were measured using the Symptom Checklist-90-Revised (SCL-90-R). Data collected from donors were compared to previ- ously published data from the general population. Clin- ical and demographic data were collected from medical records and questionnaires.RESULTS: The general health score of the SF-36 was significantly lower in females (59.78 ± 12.25) than in males (75.83 ± 22.09). Donors more than 40 years old scored higher in social functioning (85.71 ± 14.59) and mental health (82.61 ± 20.00) than those younger than 40 (75.00 ± 12.13, 68.89 ± 12.98; social func- tioning and mental health, respectively). Donors who had surgery more than two years prior to the study scored highest in physical functioning (P = 0.001) and bodily pain (P = 0.042) while those less than one year from surgery scored lowest. The health of the liver recipient significantly influenced the general health (P = 0.042), social functioning (P = 0.010), and role- emotional (P = 0.028) of donors. Donors with full-time employment scored highest in role-physical (P = 0.005), vitality (P = 0.001), social functioning (P = 0.016), mental health (P < 0.001), the physical component summary scale (P < 0.001), and the mental compo- nent summary scale (MCS) (P < 0.001). Psychological measures indicated that donors were healthier than the general population in obsessive-compulsive behav- ior, interpersonal sensitivity, phobic anxiety, and para- noid ideation. The MCS of the SF-36 was significantly correlated with most symptom scores of the SCL-90-R. CONCLUSION: HRQoL and psychological outcome were favorable in living liver transplant donors after donation. Specifically, gender, age, time since opera- tion, recipient health condition, and employment after donation, influenced postoperative quality of life.

Thermodynamic properties of two-dimensional charged spin-1/2 Fermi gases

Based on the mean-field theory,we investigate the thermodynamic properties of the two-dimensional(2D)charged spin-1/2 Fermi gas.Lande′factor g is introduced to measure the strength of the paramagnetic effect.There is a competition between diamagnetism and paramagnetism in the system.The larger the Lande′factor,the smaller the entropy and specific heat.Diamagnetism tends to increase the entropy,while paramagnetism leads to the decrease of the entropy.We find that there exists a critical value of Lande′factor for the transition point due to the competition.The entropy of the system increases with the magnetic field when g<0.58.With the growth of paramagnetism,when g>0.58,the entropy first decreases with the magnetic field,then reaches a minimum value,and finally increases again.Both the entropy and specific heat increase with the temperature,and no phase transition occurs.The specific heat tends to a constant value at the hightemperature limit,and it approaches to zero at very low temperatures,which have been proved by the analytical calculation.

Epidemiological and virological surveillance of influenza viruses in China during 2020–2021

Background: During the coronavirus disease 2019(COVID-19)pandemic,seasonal influenza activity declined globally and remained below previous seasonal levels,but intensified in China since 2021.Preventive measures to COVID-19 accompanied by different epidemic characteristics of influenza in different regions of the world.To better respond to influenza outbreaks under the COVID-19 pandemic,we analyzed the epidemiology,antigenic and genetic characteristics,and antiviral susceptibility of influenza viruses in the mainland of China during 2020–2021.Methods: Respiratory specimens from influenza like illness cases were collected by sentinel hospitals and sent to network laboratories in Chinese National Influenza Surveillance Network.Antigenic mutation analysis of influenza virus isolates was performed by hemagglutination inhibition assay.Next-generation sequencing was used for genetic analyses.We also conducted molecular characterization and phylogenetic analysis of circulating influenza viruses.Viruses were tested for resistance to antiviral medications using phenotypic and/or sequence-based methods.Results: In the mainland of China,influenza activity recovered in 2021 compared with that in 2020 and intensified during the traditional influenza winter season,but it did not exceed the peak in previous years.Almost all viruses isolated during the study period were of the B/Victoria lineage and were characterized by genetic diversity,with the subgroup 1A.3a.2 viruses currently predominated.37.8%viruses tested were antigenically similar to reference viruses representing the components of the vaccine for the 2020–2021 and 2021–2022 Northern Hemisphere influenza seasons.In addition,China has a unique subgroup of 1A.3a.1 viruses.All viruses tested were sensitive to neuraminidase inhibitors and endonuclease inhibitors,except two B/Victoria lineage viruses identified to have reduced sensitivity to neuraminidase inhibitors.Conclusions: Influenza activity increased in the mainland of China in 2021,and caused flu season in the winter of 2021–2022.Although the diversity of influenza(sub)type decreases,B/Victoria lineage viruses show increased genetic and antigenic diversity.The world needs to be fully prepared for the co-epidemic of influenza and severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)virus globally.